23.6 C
State of Tripura
Monday, October 27, 2025

Tripura CM launches Samriddhi Abhiyan empowering Rural Women Entrepreneurs

Tripura CM launches Samriddhi Abhiyan, empowering 4.86...

Tripura CM Saha vows tribal growth after 6,400 join BJP

Over 6,400 tribal voters joined the BJP...

Communal clash rocks Santirbazar, 10 injured including Top Officials

Communal tensions flare up in Santirbazar, Kamalpur...

India developing Multi-Stage Malaria Vaccine Candidate named AdFalciVax

Must Read

India is developing a Multi-Stage Malaria Vaccine Candidate named AdFalciVax. The vaccine aims to provide protection against human infection while also reducing vector-borne community transmission of the parasite. AdFalciVax is the first indigenous recombinant chimeric malaria vaccine specifically designed to target two critical stages of Plasmodium falciparum, the parasite responsible for the most lethal form of malaria.
 
The Indian Council of Medical Research (ICMR), through in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing this malaria vaccine candidate. The vaccine has shown excellent efficacy in the preclinical stage of development. As an indigenously developed vaccine candidate fulfilling the Make in India mandate, AdFalciVax holds the potential to contribute substantially toward malaria eradication by preventing infection and minimizing community transmission. The vaccine candidate is in its early research and development phases and is not yet available for any clinical use or commercialization.
 

- Advertisement -
spot_img
spot_img
spot_img
spot_img
spot_img

Latest News

17-Year-Old Anahat Singh Beats World No. 20 Melissa Alves to Reach Canadian Open Quarters

Reigning national squash champion Anahat Singh has defeated world No. 20 Melissa Alves of France to enter...